Indian drug makers face a critical shortage of essential raw materials. Pharmexcil has asked the government to divert supplies of propylene, methanol, ammonia, and butane. These are vital for producing solvents and active pharmaceutical ingredients. Low inventories at solvent manufacturers threaten medicine availability. The government is considering quotas to support the pharma sector.